DISTINCT ANTI-TUMOR RESPONSE TO LISTERIA-BASED VACCINES BETWEEN ORTHOTOPIC AND SUBCUTANEOUS SYNGENEIC MOUSE MODELS OF RENAL CELL CARCINOMA

被引：0
|
作者：
Nguyen, Hong-My [1 ]
Wood, Laurence [1 ]
机构：
[1] Texas Tech Univ, Hlth Sci Ctr, Abilene, TX USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.1370
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1370
引用
下载
收藏
页码：A1422 / A1423
页数：2
相关论文
共 34 条
  • [1] A Listeria-based vaccine targeting ISG15 exerts anti-tumor efficacy in renal cell carcinoma
    Hong-My Nguyen
    Mariam Oladejo
    Wyatt Paulishak
    Laurence M. Wood
    Cancer Immunology, Immunotherapy, 2023, 72 : 2889 - 2903
  • [2] A Listeria-based vaccine targeting ISG15 exerts anti-tumor efficacy in renal cell carcinoma
    Nguyen, Hong-My
    Oladejo, Mariam
    Paulishak, Wyatt
    Wood, Laurence M.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (09) : 2889 - 2903
  • [3] Comparison of subcutaneous and orthotopic tumor growth in syngeneic mouse models of ovarian and renal cancer
    Suominen, Mari I.
    Zdrojewska, Justyna
    Konkol, Yvonne
    Fagerlund, Katja M.
    Ristola, Mervi
    Rissanen, Jukka P.
    CANCER RESEARCH, 2023, 83 (07)
  • [4] Listeria-based immunotherapy directed against CD105 exerts anti-angiogenic and anti-tumor efficacy in renal cell carcinoma
    Oladejo, Mariam
    Nguyen, Hong-My
    Silwal, Ashok
    Reese, Britney
    Paulishak, Wyatt
    Markiewski, Maciej M. M.
    Wood, Laurence M. M.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [5] LISTERIA-BASED IMMUNOTHERAPY SCULPTS CD8+ T CELL RESPONSE IN THE TUMOR MICROENVIRONMENT TO CONTROL RENAL CELL CARCINOMA
    Oladejo, Mariam
    Wood, Laurence
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1223 - A1224
  • [6] Listeria-Based Vaccines Targeting Interferon-Stimulated Gene 15 (ISG15) for Renal Cell Carcinoma and Colorectal Cancer
    Nguyen, H. M.
    Wood, L. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E511 - E511
  • [7] Synergistic anti-tumor effect of 13-cRA and IFN-α/β in mouse, renal cell carcinoma
    Taguchi, I
    Hara, I
    Gohji, K
    Arakawa, S
    Kamidono, S
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 13 (01) : 145 - 149
  • [8] Tumor Resistance to Anti-angiogenic Therapies in Renal Cell Carcinoma Tumorgraft Mouse Models
    Jimenez, G.
    Martinez, M.
    Moserle, L.
    Vidal, A.
    Casanovas, O.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S104 - S104
  • [9] Ibrutinib regulates tumor microenvironment and enhances response to everolimus in renal cell carcinoma mouse models
    Chen, Jun
    Chen, Chun-Te
    Liu, Jing
    Hsu, Jeff
    Kinoshita, Taisei
    Chang, Betty Y.
    CANCER RESEARCH, 2017, 77
  • [10] Anti-tumor efficacy of 0114 blockade in combination with sunitinib or aflibercept in primary human renal cell carcinoma models
    Miles, Kiersten Marie
    Gillard, Bryan
    Kuhnert, Frank
    Thurston, Gavin
    Lalani, Alshad S.
    Pili, Roberto
    CANCER RESEARCH, 2012, 72
1234